跳至主要内容
临床试验/CTRI/2015/08/006114
CTRI/2015/08/006114已完成1 期

PHARMACEUTICAL STUDY OF SWARNA MAKSHIKA BHASMA AND ITS CLINICAL EFFICACY IN MADHUMEHA (DM TYPE-II) - SMB

IPGT and RA0 个研究点目标入组 110 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
110

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients having classical symptomatology of Madhumeha (Prabhutamutrata, Avilamutrata etc) will be selected from O.P.D. and I.P.D. of I.P.G.T. & R.A., Hospital, Jamnagar.
  • 2.Symptoms of Diabetes (Polyuria, Polydypsia, Polyphagia and Weight loss.)
  • 3.Both the sexes having Age between 30 years to 60 years.
  • 4.Patients having Blood sugar â?? FBS >= 126 mg/dl
  • â?? PPBS >= 200 mg/dl

排除标准

  • 1.Age below 30 and above 60 years.
  • 2.Malignant and accelerated Hypertension.
  • 3.Patients having chronic complications of Diabetes Mellitus
  • a.Microvascular: Retinopathy, Neuropathy, & Nephropathy.
  • b.Macrovascular: Coronary artery disease, Peripheral vascular disease & Cerebro-vascular disease.
  • c.Other chronic debilitating diseases like STD etc.
  • 4.Pregnant women.
  • 5.Lactating mothers.
  • 6.Secondary Diabetes mellitus.
  • 7.Patients of any other severe illness.

研究者

发起方
IPGT and RA

相似试验